Hamilton Thorne Ltd.
HTL
Rang in Aktien
#16956
Hamilton Thorne Ltd. is a leading enterprise focused on the development,... Hamilton Thorne Ltd. is a leading enterprise focused on the development, manufacturing, and global distribution of specialized instrumentation, laboratory equipment, consumables, software, and a range of services. The company's offerings are primarily directed towards the fields of assisted reproductive technologies (ART), scientific research, and cell biology. Their product line includes sophisticated laser and imaging systems designed for biological studies, custom-built workstations, incubators, and essential equipment for IVF laboratories. They also produce critical medical devices for reproductive medicine, such as ovum pickup needles and catheters, and provide comprehensive in-vitro diagnostic (IVD) systems, from initial research and design to sales, installation, and ongoing servicing. Environmental control solutions like the Cell-Tek Microscope Chamber, which meticulously manages temperature, airflow, and humidity, are also part of their extensive catalog, alongside laminar flow workstations. Furthermore, Hamilton Thorne pioneers software innovations, including AI-powered CASA (Computer-Assisted Sperm Analysis) for image analysis. The company's service array covers thorough laboratory testing, notably endotoxin analysis and specialized sperm assays (like the Sperm Motility Index and Sperm Penetration), as well as the provision of fresh and cryopreserved mouse embryos, coupled with technician training and proficiency testing programs. Marketed under respected brand names such as Hamilton Thorne, Gynemed, Planer, Tek-Event, IVFtech, MICROPTIC, Gynétics, and Embryotech, their products and services reach a diverse global customer base—including fertility clinics, hospitals, pharmaceutical and biotechnology companies, academic institutions, and various commercial research entities—via a direct sales presence in countries like the United States, Germany, France, Australia, Denmark, Belgium, Spain, and the United Kingdom, complemented by an extensive distributor network covering around 100 nations. Hamilton Thorne Ltd. maintains its headquarters in Beverly, Massachusetts.
Aktienkurs
$1.64
Zuletzt synchronisiert: 2024-12-02
Marktkapitalisierung
$253.46M
Veränderung (1 Tag)
2.87%
Veränderung (1 Jahr)
3.40%
Land
US
Handel Hamilton Thorne Ltd. (HTL)
Kategorie
Healthcare
EPS für Hamilton Thorne Ltd. (HTL)
EPS zum September 2024 TTM: $-0.01
Laut den aktuellen Finanzberichten und dem Aktienkurs von Hamilton Thorne Ltd. beträgt das aktuelle EPS des Unternehmens (TTM) $-0.01. Am Ende des Jahres 2022 betrug das EPS $0.01 ein Rückgang im Vergleich zu dem EPS von 2021, das $0.02 betrug.
EPS-Verlauf von Hamilton Thorne Ltd. von 2008 bis 2026
EPS am Ende jedes Jahres
| Jahr | EPS | ändert |
|---|---|---|
| 2026 (TTM) | $-0.01 | -132.03% |
| 2023 | 0.00 | -132.03% |
| 2022 | $0.01 | -25.58% |
| 2021 | $0.02 | 126.32% |
| 2020 | $0.01 | 15.15% |
| 2019 | $0.01 | -71.91% |
| 2018 | $0.02 | -59.48% |
| 2017 | $0.06 | 480.00% |
| 2016 | $0.01 | -50.00% |
| 2015 | $0.02 | 0.00% |
| 2014 | $0.02 | 733.33% |
| 2013 | 0.00 | -107.27% |
| 2012 | $-0.03 | -45.81% |
| 2011 | $-0.06 | -19.34% |
| 2010 | $-0.08 | -21.11% |
| 2009 | $-0.10 | -36.20% |
| 2008 | $-0.15 | 0.00% |
EPS für ähnliche Unternehmen oder Wettbewerber
| Unternehmen | EPS | EPS-Differenz | Land |
|---|---|---|---|
| $8.85 | -65,655.56% |
US
|
|
| $6.41 | -47,545.93% |
FR
|
|
| - | - |
JP
|
|
| $3.32 | -24,692.59% |
US
|
|
| - | - |
CH
|
